SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-244850
Filing Date
2010-11-03
Accepted
2010-11-02 20:40:59
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 427648
2 FIFTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT dex101.htm EX-10.1 42773
3 SIXTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT dex102.htm EX-10.2 9852
4 CEO CERTIFICATION dex311.htm EX-31.1 9072
5 CFO CERTIFICATION dex312.htm EX-31.2 9228
6 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 3701
  Complete submission text file 0001193125-10-244850.txt   503744
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 101159743
SIC: 2836 Biological Products, (No Diagnostic Substances)